Patient perspectives on symptoms, health-related quality of life, and treatment experience associated with relapsed/refractory multiple myeloma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patient perspectives on symptoms, health-related quality of life, and treatment experience associated with relapsed/refractory multiple myeloma
Authors
Keywords
-
Journal
SUPPORTIVE CARE IN CANCER
Volume 30, Issue 7, Pages 5859-5869
Publisher
Springer Science and Business Media LLC
Online
2022-04-02
DOI
10.1007/s00520-022-06979-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Harnessing the Immune System Against Multiple Myeloma: Challenges and Opportunities
- (2021) Leona Yamamoto et al. Frontiers in Oncology
- Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life
- (2021) Evangelos Terpos et al. Blood Cancer Journal
- Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019
- (2021) Linghui Zhou et al. BMC CANCER
- Dissecting racial disparities in multiple myeloma
- (2020) Catherine R. Marinac et al. Blood Cancer Journal
- Immunotherapy of multiple myeloma
- (2020) Simone A. Minnie et al. JOURNAL OF CLINICAL INVESTIGATION
- Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results
- (2020) Saad Z. Usmani et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Treatment preferences of patients with relapsed and refractory multiple myeloma: a qualitative study
- (2019) Janet A. Parsons et al. BMC CANCER
- Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline
- (2019) Joseph Mikhael et al. JOURNAL OF CLINICAL ONCOLOGY
- Patient‐Reported Factors in Treatment Satisfaction in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
- (2019) Ajai Chari et al. ONCOLOGIST
- Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care in the United States
- (2018) Parameswaran Hari et al. Clinical Lymphoma Myeloma & Leukemia
- Global Burden of Multiple Myeloma
- (2018) Andrew J. Cowan et al. JAMA Oncology
- Treatment of relapsed refractory multiple myeloma: which new PI-based combination treatments do patients prefer?
- (2018) Thomas Wilke et al. Patient Preference and Adherence
- Patient Preferences Regarding Treatment Options for Relapsed Refractory Multiple Myeloma (RRMM)
- (2017) S Bauer et al. VALUE IN HEALTH
- Multiple myeloma
- (2017) Shaji K. Kumar et al. Nature Reviews Disease Primers
- Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: increased options and increased complexity
- (2016) R F Cornell et al. BONE MARROW TRANSPLANTATION
- Future distribution of multiple myeloma in the United States by sex, age, and race/ethnicity
- (2015) P. S. Rosenberg et al. BLOOD
- Optimizing quality of life in multiple myeloma patients: current options, challenges and recommendations
- (2015) Helena Maes et al. Expert Review of Hematology
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
- (2013) S K Kumar et al. LEUKEMIA
- Emerging therapies for the treatment of relapsed or refractory multiple myeloma
- (2010) Meletios A. Dimopoulos et al. EUROPEAN JOURNAL OF HAEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation